TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin

Immunoglobulins
UK
Published value
Not published
Submission deadline Not published
Lots published6
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS England: "NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin". Published status: complete. Published value: Value not published. 6 published lots. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityNHS EnglandScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: NHS England
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for NHS England. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
6.1Bids / Report
35% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 182 active published awards; 180 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNHS England
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSFramework
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published20 Jan 2025, 15:25 GMT
Last source update20 Jan 2025, 15:25 GMT
Recurring procurementNot published
ClassificationImmunoglobulins
Delivery area
UK
OCIDocds-h6vhtk-048730
What is being bought
NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin<br/><br/>Offer reference number: CM/PHS/23/5703<br/><br/>The period of the framework is 1 April 2025 to 31 December 2027 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 15 months. The total maximum framework agreement duration, including extension options, will be no more than 48 months.
What changed
From the official release history
  1. tender value changed
    20 Jan 2025, 15:25 GMT
  2. Status changed to complete
    20 Jan 2025, 15:25 GMT
  3. Official notice release published
    20 Jan 2025, 15:25 GMT
  4. Submission deadline changed to published date
    20 Jan 2025, 15:25 GMT
  5. Buyer information updated
    20 Jan 2025, 15:25 GMT
  6. Published value updated to £1,700,000,000
    2 Aug 2024, 13:44 BST
  7. Status changed to active
    2 Aug 2024, 13:44 BST
  8. Official notice release published
    2 Aug 2024, 13:44 BST
  9. Submission deadline changed to 13 Sept 2024, 13:00 BST
    2 Aug 2024, 13:44 BST
  10. Buyer information updated
    2 Aug 2024, 13:44 BST
Lots and requirements (6)
Published by the contracting authority
  • Lot 1 · #1
    Lot 1 - Low and High Strength Albumin
    cancelled
    Published valueNot published
    NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin<br/><br/>Offer reference number: CM/PHS/23/5703<br/><br/>Period of framework agreement: 1 April 2025 to 31 December 2027 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 15 months. The total maximum framework agreement duration, including extension options, will be no more than 48 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 2 · #2
    Lot 2 - 5% Intravenous Immunoglobulin
    cancelled
    Published valueNot published
    NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin<br/><br/>Offer reference number: CM/PHS/23/5703<br/><br/>Period of framework agreement: 1 April 2025 to 31 December 2027 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 15 months. The total maximum framework agreement duration, including extension options, will be no more than 48 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 3 · #3
    Lot 3 - 10% Intravenous Immunoglobulin
    cancelled
    Published valueNot published
    NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin<br/><br/>Offer reference number: CM/PHS/23/5703<br/><br/>Period of framework agreement: 1 April 2025 to 31 December 2027 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 15 months. The total maximum framework agreement duration, including extension options, will be no more than 48 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 4 · #4
    Lot 4 - Subcutaneous Immunoglobulin
    cancelled
    Published valueNot published
    NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin<br/><br/>Offer reference number: CM/PHS/23/5703<br/><br/>Period of framework agreement: 1 April 2025 to 31 December 2027 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 15 months. The total maximum framework agreement duration, including extension options, will be no more than 48 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 5 · #5
    Lot 5 - Facilitated Subcutaneous Immunoglobulin
    cancelled
    Published valueNot published
    NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin<br/><br/>Offer reference number: CM/PHS/23/5703<br/><br/>Period of framework agreement: 1 April 2025 to 31 December 2027 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 15 months. The total maximum framework agreement duration, including extension options, will be no more than 48 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 6 · #6
    Lot 6 - Anti-D Immunoglobulin
    cancelled
    Published valueNot published
    NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin<br/><br/>Offer reference number: CM/PHS/23/5703<br/><br/>Period of framework agreement: 1 April 2025 to 31 December 2027 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 15 months. The total maximum framework agreement duration, including extension options, will be no more than 48 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    20 Jan 2025, 15:25 GMT
  2. Award active
    Not published · Not published
  3. Award active
    Not published · Not published
  4. Award active
    Not published · Not published
  5. Award active
    Not published · Not published
  6. Award active
    Not published · Not published
  7. Award active
    Not published · Not published
  8. Award active
    Not published · Not published
  9. Award active
    Not published · Not published
  10. Award active
    Not published · Not published
  11. Award active
    Not published · Not published
  12. Award active
    Not published · Not published
  13. Award active
    Not published · Not published
  14. Award active
    Not published · Not published
  15. Award active
    Not published · Not published
  16. Award active
    Not published · Not published
  17. Award active
    Not published · Not published
  18. Award active
    Not published · Not published
  19. Award active
    Not published · Not published
  20. Award active
    Not published · Not published
  21. Contract active
    Signed 19 Dec 2024, 00:00 GMT · £1
  22. Contract active
    Signed 19 Dec 2024, 00:00 GMT · £1
  23. Contract active
    Signed 19 Dec 2024, 00:00 GMT · £1
  24. Contract active
    Signed 19 Dec 2024, 00:00 GMT · £1
  25. Contract active
    Signed 19 Dec 2024, 00:00 GMT · £1
  26. Contract active
    Signed 19 Dec 2024, 00:00 GMT · £1
  27. Contract active
    Signed 19 Dec 2024, 00:00 GMT · £1
  28. Contract active
    Signed 19 Dec 2024, 00:00 GMT · £1
  29. Contract active
    Signed 19 Dec 2024, 00:00 GMT · £1
  30. Contract active
    Signed 19 Dec 2024, 00:00 GMT · £1
  31. Contract active
    Signed 19 Dec 2024, 00:00 GMT · £1
  32. Contract active
    Signed 19 Dec 2024, 00:00 GMT · £1
  33. Contract active
    Signed 19 Dec 2024, 00:00 GMT · £1
  34. Contract active
    Signed 19 Dec 2024, 00:00 GMT · £1
  35. Contract active
    Signed 19 Dec 2024, 00:00 GMT · £1
  36. Contract active
    Signed 19 Dec 2024, 00:00 GMT · £1
  37. Contract active
    Signed 19 Dec 2024, 00:00 GMT · £1
  38. Contract active
    Signed 19 Dec 2024, 00:00 GMT · £1
  39. Contract active
    Signed 19 Dec 2024, 00:00 GMT · £1
Commercial outcome and competition
Awards
CSL BEHRING UK LIMITED
Not published · Not published · active
Grifols UK (Diagnostics)
Not published · Not published · active
Octapharma Limited
Not published · Not published · active
LFB BIOMEDICAMENTS
Not published · Not published · active
CSL BEHRING UK LIMITED
Not published · Not published · active
Takeda UK Limited
Not published · Not published · active
Grifols UK (Diagnostics)
Not published · Not published · active
Octapharma Limited
Not published · Not published · active
Takeda UK Limited
Not published · Not published · active
CSL BEHRING UK LIMITED
Not published · Not published · active
BIO PRODUCTS LABORATORY LIMITED
Not published · Not published · active
Grifols UK (Diagnostics)
Not published · Not published · active
Octapharma Limited
Not published · Not published · active
Takeda UK Limited
Not published · Not published · active
Grifols UK (Diagnostics)
Not published · Not published · active
Octapharma Limited
Not published · Not published · active
CSL BEHRING UK LIMITED
Not published · Not published · active
BIO PRODUCTS LABORATORY LIMITED
Not published · Not published · active
Takeda UK Limited
Not published · Not published · active
Contracts
NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
£1 · signed 19 Dec 2024, 00:00 GMT · active
NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
£1 · signed 19 Dec 2024, 00:00 GMT · active
NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
£1 · signed 19 Dec 2024, 00:00 GMT · active
NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
£1 · signed 19 Dec 2024, 00:00 GMT · active
NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
£1 · signed 19 Dec 2024, 00:00 GMT · active
NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
£1 · signed 19 Dec 2024, 00:00 GMT · active
NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
£1 · signed 19 Dec 2024, 00:00 GMT · active
NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
£1 · signed 19 Dec 2024, 00:00 GMT · active
NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
£1 · signed 19 Dec 2024, 00:00 GMT · active
NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
£1 · signed 19 Dec 2024, 00:00 GMT · active
NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
£1 · signed 19 Dec 2024, 00:00 GMT · active
NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
£1 · signed 19 Dec 2024, 00:00 GMT · active
NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
£1 · signed 19 Dec 2024, 00:00 GMT · active
NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
£1 · signed 19 Dec 2024, 00:00 GMT · active
NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
£1 · signed 19 Dec 2024, 00:00 GMT · active
NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
£1 · signed 19 Dec 2024, 00:00 GMT · active
NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
£1 · signed 19 Dec 2024, 00:00 GMT · active
NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
£1 · signed 19 Dec 2024, 00:00 GMT · active
NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
£1 · signed 19 Dec 2024, 00:00 GMT · active
Bid statistics
bids: 6
bids: 6
bids: 6
electronicBids: 6
electronicBids: 6
electronicBids: 6
smeBids: 0
smeBids: 0
smeBids: 0
bids: 6 (lot 2)
bids: 6 (lot 2)
bids: 6 (lot 2)
electronicBids: 6 (lot 2)
electronicBids: 6 (lot 2)
electronicBids: 6 (lot 2)
smeBids: 0 (lot 2)
smeBids: 0 (lot 2)
smeBids: 0 (lot 2)
bids: 6 (lot 3)
bids: 6 (lot 3)
bids: 6 (lot 3)
bids: 6 (lot 3)
bids: 6 (lot 3)
bids: 6 (lot 3)
electronicBids: 6 (lot 3)
electronicBids: 6 (lot 3)
electronicBids: 6 (lot 3)
electronicBids: 6 (lot 3)
electronicBids: 6 (lot 3)
electronicBids: 6 (lot 3)
smeBids: 0 (lot 3)
smeBids: 0 (lot 3)
smeBids: 0 (lot 3)
smeBids: 0 (lot 3)
smeBids: 0 (lot 3)
smeBids: 0 (lot 3)
bids: 6 (lot 4)
bids: 6 (lot 4)
bids: 6 (lot 4)
bids: 6 (lot 4)
electronicBids: 6 (lot 4)
electronicBids: 6 (lot 4)
electronicBids: 6 (lot 4)
electronicBids: 6 (lot 4)
smeBids: 0 (lot 4)
smeBids: 0 (lot 4)
smeBids: 0 (lot 4)
smeBids: 0 (lot 4)
bids: 6 (lot 5)
electronicBids: 6 (lot 5)
Buyer and organisations in this procedure

NHS England

Contracting authority GB-FTS-107961
View buyer profile

  • NHS England
    buyer

    7-8 Wellington Place, Leeds, UK, LS1 4AP
    michelle.clarke6@nhs.net

  • BIO PRODUCTS LABORATORY LIMITED
    supplier

    07343036
    C/O Bio Products Laboratory, Dagger Lane, Elstree, Hertfordshire, WD6 3BX, Elstree, UK, WD6 3BX

  • BIO PRODUCTS LABORATORY LIMITED
    supplier

    07343036
    C/O Bio Products Laboratory, Dagger Lane, Elstree, Hertfordshire, WD6 3BX, ELSTREEE, UK, WD6 3BX

  • CSL BEHRING UK LIMITED
    supplier

    01622483
    4 Milton Road Haywards Heath West Sussex, Haywards Heath, UK, RH16 1AH

  • Grifols UK (Diagnostics)
    supplier

    01456099
    6th Floor One London Wall, London, EC2Y 5EB, LONDON, UK, EC2Y 5EB

  • LFB BIOMEDICAMENTS
    supplier

    491371167
    3 AVENUE DES TROPIQUES 91940 LES ULIS FRANCE, Les Ulis, FR, 91958
    +33 169827010

  • Octapharma Limited
    supplier

    02372699
    Octapharma Ltd, 32 Shudehill, Manchester, M4 1EZ, Manchester, UK, M4 1EZ

  • Takeda UK Limited
    supplier

    03362860
    1 Kingdom Street, LONDON, UK, W2 6BD
    contracts.uk@takeda.com

  • The High Court
    reviewBody

    The Strand, London, WC2A 2LL
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published